Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects (clinicaltrials.gov) - Feb 15, 2024 - P1 | N=88 | Completed | Sponsor: Chong Kun Dang Pharmaceutical | Recruiting ➔ Completed | Trial completion date: Sep 2022 ➔ Jul 2023 | Trial primary completion date: Sep 2022 ➔ Jul 2023
First-in-human • Trial completion • Trial completion date • Trial primary completion date
|